Stephen J. DiPalma

Insider Reports History

Reporting-owner location: Cambridge, MA
Latest reporting-owner signature: /s/ Tamara Joseph. Attorney-in-Fact for Stephen J. DiPalma
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Stephen J. DiPalma

Form 4 holding Interim CFO

Inozyme Pharma, Inc.

Security class: Stock option (Right to Buy)
Shares / value: 15,000
Estimated value
Report date: 17 May 2021
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Insider Reports Filed by Stephen J. DiPalma

3 SPRO

Spero Therapeutics, Inc.

Report period: 15 Jul 2023
Transactions: 0
Transaction value: $0
Accepted by SEC: 24 Jul 2023, 16:46
Role: Interim Chief Financial Officer Exhibit 24.1 - Power of Attorney
Next action: Open filing details

4 INZY

Inozyme Pharma, Inc.

Report period: 17 May 2021
Transactions: 1
Transaction value: $0
Accepted by SEC: 18 May 2021, 16:18
Role: Interim CFO
Next action: Open filing details

3 INZY

Inozyme Pharma, Inc.

Report period: 17 May 2021
Transactions: 0
Transaction value: $0
Accepted by SEC: 18 May 2021, 16:07
Role: Interim CFO
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .